Related Experiment Video
Updated: Dec 3, 2025

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Pyridine alkaloids with activity in the central nervous system
Simon X Lin1, Maurice A Curtis2, Jonathan Sperry1
1School of Chemical Sciences, University of Auckland, Auckland, New Zealand.
This review explores pyridine alkaloids that impact the central nervous system (CNS). It covers their therapeutic uses and diverse natural origins.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Neuroscience
Background:
- Pyridine alkaloids represent a significant class of naturally occurring compounds.
- Many pyridine alkaloids exhibit notable biological activities, particularly affecting the central nervous system (CNS).
- Understanding their sources and therapeutic potential is crucial for drug discovery.
Purpose of the Study:
- To comprehensively review pyridine alkaloids with demonstrated CNS activity.
- To elucidate the therapeutic potential of these compounds.
- To identify and discuss the diverse natural sources of these bioactive alkaloids.
Main Methods:
- Literature review of scientific databases (e.g., PubMed, Scopus).
- Systematic search for studies on pyridine alkaloids and CNS activity.
- Analysis of reported therapeutic applications and natural origins.
Main Results:
- Identification of numerous pyridine alkaloids exhibiting various CNS effects.
- Summary of established and potential therapeutic applications, including neurological and psychiatric disorders.
- Cataloging of plant and animal sources, highlighting biosynthetic pathways.
Conclusions:
- Pyridine alkaloids are a rich source of CNS-active compounds with significant therapeutic promise.
- Further research into their mechanisms of action and clinical efficacy is warranted.
- Exploration of their natural origins can guide the discovery of novel analogs.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Affecting Neurotransmitter Release or Uptake